Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CinnaTropin vs Nordilet in Children with IGHD
NCT03223025Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Mar 2016
- Primary completion
- Feb 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of somatropin in idiopathic growth hormone deficiency (I-GHD), sponsored by CinnaGen. Started Mar 2016; status: completed.
02
Drugs
somatropin
03
Conditions
idiopathic growth hormone deficiency (I-GHD)
Beyond the preview
Go deeper on NCT03223025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223025.